Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Molecular Pharmaceutics|September 18, 2023
Controlling Antigen Fate in Therapeutic Cancer Vaccines by Targeting Dendritic Cell ReceptorsZacharias Wijfjes, Floris J van Dalen, Camille M Le Gall, et al.RSC Chemical Biology|June 12, 2025
<i>trans</i>-Cyclooctene-caged-IL-1β immunocytokine-constructs ligated to unmodified nanobodies allow click-2-release-based control of cytokine activityAmber Barendrecht, Heleen H C Peeters, Diana Torres-García, et al.Bioconjugate Chemistry|January 21, 2021
Dual Site-Specific Chemoenzymatic Antibody Fragment Conjugation Using CRISPR-Based Hybridoma EngineeringCamille M Le Gall, Johan M S van der Schoot, Iván Ramos-Tomillero, et al.RSC Chemical Biology|May 9, 2025
Co-delivery of antigen and adjuvant by site-specific conjugation to dendritic cell-targeted Fab fragments potentiates T cell responsesZacharias Wijfjes, Iván Ramos Tomillero, Camille M Le Gall, et al.Science Advances|September 7, 2019
Functional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineeringJohan M S van der Schoot, Felix L Fennemann, Michael Valente, et al.Nature Biomedical Engineering|April 9, 2025
Site-directed multivalent conjugation of antibodies to ubiquitinated payloadsAngela F El Hebieshy, Zacharias Wijfjes, Camille M Le Gall, et al.Nature Communications|June 3, 2024
Generation of nanobodies from transgenic 'LamaMice' lacking an endogenous immunoglobulin repertoireThomas Eden, Alessa Z Schaffrath, Janusz Wesolowski, et al.Pageof 1